Ya-Zhen Qin

Ya-Zhen Qin, Yan-rong Liu, Yu-Hong Chen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Which method better evaluates the molecular response in newly diagnosed chronic phase chronic myeloid leukemia patients with imatinib treatment, BCR-ABL(IS) or log reduction from the baseline level?

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2013, Leukemia research.

Wilms’ tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation

Ya-Zhen Qin, Yu-Hong Chen, Yu Wang, 2021, BMC cancer.

Immunophenotypic characteristics of ZNF384 rearrangement compared with BCR‐ABL1, KMT2A rearrangement, and other adult B‐cell precursor acute lymphoblastic leukemia

Hao Jiang, Ya-Zhen Qin, Q. Jiang, 2022, Cytometry. Part B, Clinical cytometry.

CXCR4 is a good survival prognostic indicator in multiple myeloma patients.

Ya-Zhen Qin, Q. Jiang, Yan-rong Liu, 2013, Leukemia research.

G-protein coupled receptor 34 activates Erk and phosphatidylinositol 3-kinase/Akt pathways and functions as alternative pathway to mediate p185Bcr–Abl-induced transformation and leukemogenesis

Ya-Zhen Qin, Weidong Yu, Yulan Liu, 2015, Leukemia & lymphoma.

Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial

Dajun Yang, Ya-Zhen Qin, Q. Jiang, 2022, Journal of Hematology & Oncology.

Ruxolitinib/nilotinib cotreatment inhibits leukemia-propagating cells in Philadelphia chromosome-positive ALL

Hao Jiang, Yi-Lin Wu, Ya-Zhen Qin, 2017, Journal of Translational Medicine.

Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2016, Medicine.

Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2021, Leukemia & lymphoma.

Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation

Ya-Zhen Qin, Yu-Hong Chen, Yu Wang, 2021, Annals of Hematology.

Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single center

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2021, Annals of Hematology.

The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia

Ya-Zhen Qin, Yu-Hong Chen, Yu Wang, 2017, Journal of Hematology & Oncology.

Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation

R. Gale, Ya-Zhen Qin, Hao Jiang, 2016, Chinese journal of cancer.

Monitoring mixed lineage leukemia expression may help identify patients with mixed lineage leukemia--rearranged acute leukemia who are at high risk of relapse after allogeneic hematopoietic stem cell transplantation.

Ya-Zhen Qin, Yu Wang, Lanping Xu, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Two Single-Nucleotide Polymorphisms with Linkage Disequilibrium in the Human Programmed Cell Death 5 Gene 5′ Regulatory Region Affect Promoter Activity and the Susceptibility of Chronic Myelogenous Leukemia in Chinese Population

Ya-Zhen Qin, Yan-rong Liu, G. Ruan, 2005, Clinical Cancer Research.

Low IL7R Expression at Diagnosis Predicted Relapse in Adult Acute Myeloid Leukemia Patients With t(8;21)

Ya-Zhen Qin, Yan-rong Liu, Xiao-jun Huang, 2022, Frontiers in Immunology.

The Clinical Significance and Biological Function of DPEP1 in B-cell Acute Lymphoblastic Leukemia

Jiamin Zhang, Yanmei Xu, R. Gale, 2019, bioRxiv.

The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

Ya-Zhen Qin, Yu Wang, Xiao-hui Zhang, 2018, Annals of Hematology.

Molecular Detection of BCR-ABL in Chronic Myeloid Leukemia.

Ya-Zhen Qin, Xiao-jun Huang, Yazhen Qin, 2016, Methods in molecular biology.

Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity

Ya-Zhen Qin, Yan-rong Liu, Yu Wang, 2013, Annals of Hematology.

The differences and correlations of BCR‐ABL transcripts between peripheral blood and bone marrow assays are associated with the molecular responses in the bone marrow for chronic myelogenous leukemia

Ya-Zhen Qin, Q. Jiang, B. Jiang, 2012, American journal of hematology.

Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.

Ya-Zhen Qin, B. Jiang, Yan-rong Liu, 2009, Leukemia research.

Low EVI1 expression at diagnosis predicted poor outcomes in pediatric Ph-negative B cell precursor acute lymphoblastic leukemia patients

Ya-Zhen Qin, Yan-rong Liu, Wen-Min Chen, 2021, Pediatric hematology and oncology.

Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The initial level of MLL-partial tandem duplication affects the clinical outcomes in patients with acute myeloid leukemia

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2018, Leukemia & lymphoma.

CD34-Negative is Highly Associated with T (15;17), T (V; 11q23) and theNPM1-Mutation Subtypes in 343 Newly Diagnosed Patients with Acute MyeloidLeukemia

Ya-Zhen Qin, Yan-rong Liu, Honghu Zhu, 2016 .

Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21).

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2016, Leukemia research.

S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukaemia

Jiamin Zhang, Li-xin Wu, Jing Zhang, 2019, British journal of haematology.

CD38+ CD58- is an independent adverse prognostic factor in paediatric Philadelphia chromosome negative B cell acute lymphoblastic leukaemia patients.

Ya-Zhen Qin, Yan-rong Liu, Xiao-jun Huang, 2016, Leukemia research.

Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Ya-Zhen Qin, Yu-Hong Chen, Yu Wang, 2022, Frontiers in Oncology.

Molecular responses of late chronic phase chronic myeloid leukemia patients after achieving complete cytogenetic responses with imatinib treatment: a 6-year follow-up

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2008, Annals of Hematology.

Planned Pregnancy in Female Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy.

Ya-Zhen Qin, Q. Jiang, Xiaojun Huang, 2019, The oncologist.

Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era.

Ya-Zhen Qin, Yan-rong Liu, Yu-Hong Chen, 2017, Leukemia research.

The Prognostic Significance of ZNF384 Fusions in Adult Ph-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: A Comprehensive Cohort Study From a Single Chinese Center

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2021, Frontiers in Oncology.

Profiles of NK cell subsets are associated with successful tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia and changes following interferon treatment

Ya-Zhen Qin, Hao Jiang, Xiao-jun Huang, 2021, Annals of Hematology.

OTT_A_240979 7545..7553

Ya-Zhen Qin, Yan-rong Liu, Wen-Min Chen, 2020 .

Incidence, risk factors and outcomes of sinusoidal obstruction syndrome after haploidentical allogeneic stem cell transplantation

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2019, Annals of Hematology.

The prognostic significance of Wilms’ tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemia

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2019, Annals of Hematology.

The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2021, Blood Cancer Journal.

Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry Studies

Ya-Zhen Qin, Yu-Hong Chen, Yu Wang, 2022, Frontiers in Immunology.

Minimal residual disease monitoring and preemptive immunotherapy in myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation

Ya-Zhen Qin, Yu-Hong Chen, Yu Wang, 2016, Annals of Hematology.

[Immunophenotypic features of bcr/abl fusion transcript-positive B-lineage acute lymphoblast leukemia].

Ya-Zhen Qin, Yan-rong Liu, G. Ruan, 2003, Zhongguo shi yan xue ye xue za zhi.

Subgroup Analysis Can Optimize the Relapse Prediction Cutoff Value for WT1 Expression Following Allogeneic Hematologic Stem Cell Transplantation in Acute Myeloid Leukemia.

Ya-Zhen Qin, Yu Wang, Xiao-hui Zhang, 2019, The Journal of molecular diagnostics : JMD.

Prognostic value of RASD1 transcript levels in adult Philadelphia-negative B-cell acute lymphoblastic leukemia

Li-xin Wu, Jing Zhang, Ya-Zhen Qin, 2020, Hematology.

Outcome and Minimal Residual Disease Monitoring in Patients with t(16;21) Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Ya-Zhen Qin, Yu Wang, Xiao-hui Zhang, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The loss or absence of minimal residual disease of <0·1% at any time after two cycles of consolidation chemotherapy in CBFB–MYH11‐positive acute myeloid leukaemia indicates poor prognosis

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2020, British journal of haematology.

Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2015, Leukemia & lymphoma.